What is King Pharmaceuticals's price / book?

King Pharmaceuticals (KG) reported price / book of 0.7× in Q1 2026.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

King Pharmaceuticals KG Price / book

Price / book at other companies

Arch Capital GroupACGL

1.4×-0.3×

Everest GroupEG

0.9×-0.2×

SiriusPointSPNT

1.1×+0.1×

KKR & Co.KKR

2.7×-1.0×

Skyward Specialty Insurance Group, Inc.SKWD

1.6×-0.9×

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Calculated from King Pharmaceuticals’s reported figures.

market cap/total stockholders equity=0.7×

Based on the most recent quarter.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's price / book?: King Pharmaceuticals (KG) reported price / book of 0.7× in Q1 2026.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.